ARUK 2019 | Down syndrome enhances amyloid-β deposition independently of extra APP copy

Name: Down syndrome enhances amyloid-β deposition independently of extra APP copy
Uploaded: 2019-03-28T09:11:27Z
Duration: 1 min 57 s
Description: Frances Wiseman, MRes, PhD, of University College London, London, UK, discusses how Down syndrome enhances amyloid-β deposition independently of an extra copy of APP. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK. Read more about this work here: https://www.ncbi.nlm.nih.gov/pubmed/29945247

Frances Wiseman • 28 Mar 2019

ARUK 2019

Alzheimer’s Disease Dementia

Frances Wiseman, MRes, PhD, of University College London, London, UK, discusses how Down syndrome enhances amyloid-β deposition independently of an extra copy of APP. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK. Read more about this work here: https://www.ncbi.nlm.nih.gov/pubmed/29945247